Trump delays China tariffs by 90 days
The deadline to enact further reciprocal tariffs against China will be extended by 90 days, President Donald Trump announced Monday night.
“[China] continues to take significant steps toward remedying non-reciprocal trade arrangements and addressing the concerns of the United States relating to economic and national security matters,” Trump explained in an executive order.
The deadline was set to expire on Aug. 12. The new deadline is set for after midnight on Nov. 10.
While negotiations with China are worked out, a 10% reciprocal tariff rate will remain in effect until Nov. 10, according to a fact sheet provided by the White House.
“President Trump is ensuring economic cooperation between two of the largest economies in order to protect American interests, stop unfair trade practices, and strengthen America’s domestic manufacturing base,” the fact sheet read.
In April, the U.S. imposed 145% tariffs against Chinese imports and China retaliated with 125% tariffs on U.S. goods.
The countries backed off these tariffs after meeting in May. The U.S. went down to 30% tariffs while China went down to 10%.
The fact sheet said the U.S. goods trade deficit with China was $295.4 billion in 2024. The White House said this number is “already decreasing substantially.”
Latest News Stories
Manhattan Board Approves Kubota RTV Purchase for Sidewalk Plowing
Hegseth promises to fix barracks, but work could take time
‘Long overdue’: Praise for HHS’ action to bar taxpayer-funded sex-change procedures
Gas prices drop, but taxes make Illinois pricier than Midwest neighbors
Liquor License Amendments Approved for Frankfort, Joliet, and Lockport Businesses
Meeting Summary and Briefs: Will County Planning and Zoning Commission for December 16, 2025
Joliet Property Owner Cleared to Convert Non-Conforming Building into Two-Unit Residence
Colorado adopts first-of-its-kind water protections in U.S.
Epstein files redactions frustrate lawmakers
Supreme Court weighs gun owners’ challenge to IL transit carry ban
Nine pharmaceutical companies agree to most-favored-nation pricing
Congress leaves for holidays after zero progress on federal funding